CVS Health (NYSE:CVS) Trading 1.1% Higher – What’s Next?

CVS Health Co. (NYSE:CVS)’s share price rose 1.1% during trading on Wednesday . The company traded as high as $52.25 and last traded at $52.15. Approximately 1,963,067 shares were traded during trading, a decline of 86% from the average daily volume of 13,839,423 shares. The stock had previously closed at $51.57.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Barclays dropped their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Truist Financial lowered their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Stock Performance

The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a fifty day moving average price of $51.39 and a 200-day moving average price of $56.36. The firm has a market cap of $66.35 billion, a price-to-earnings ratio of 13.38, a price-to-earnings-growth ratio of 0.72 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.21 EPS. On average, analysts expect that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.05%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Edgestream Partners L.P. purchased a new position in shares of CVS Health in the 2nd quarter valued at about $1,140,000. E Fund Management Co. Ltd. increased its holdings in CVS Health by 11.0% in the second quarter. E Fund Management Co. Ltd. now owns 4,722 shares of the pharmacy operator’s stock valued at $279,000 after buying an additional 467 shares in the last quarter. Marathon Trading Investment Management LLC acquired a new stake in shares of CVS Health during the 2nd quarter valued at approximately $1,412,000. WCG Wealth Advisors LLC boosted its stake in shares of CVS Health by 24.4% during the 2nd quarter. WCG Wealth Advisors LLC now owns 28,866 shares of the pharmacy operator’s stock worth $1,705,000 after acquiring an additional 5,668 shares in the last quarter. Finally, Mark Sheptoff Financial Planning LLC grew its holdings in shares of CVS Health by 46.9% in the 2nd quarter. Mark Sheptoff Financial Planning LLC now owns 5,249 shares of the pharmacy operator’s stock worth $310,000 after acquiring an additional 1,677 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.